InvestorsObserver
×
News Home

Is Gamida Cell Ltd (GMDA) the Top Pick in the Biotechnology Industry?

Thursday, December 17, 2020 09:49 AM | InvestorsObserver Analysts

Mentioned in this article

Is Gamida Cell Ltd (GMDA) the Top Pick in the Biotechnology Industry?

The 85 rating InvestorsObserver gives to Gamida Cell Ltd (GMDA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 97 percent of stocks in the Biotechnology industry, GMDA’s 85 overall rating means the stock scores better than 85 percent of all stocks.

Overall Score - 85
GMDA has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on GMDA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 85 means the stock is more attractive than 85 percent of stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Gamida Cell Ltd Stock Today?

Gamida Cell Ltd (GMDA) stock is trading at $8.66 as of 9:41 AM on Thursday, Dec 17, a gain of $0.21, or 2.51% from the previous closing price of $8.45. The stock has traded between $8.50 and $8.91 so far today. Volume today is less active than usual. So far 81,125 shares have traded compared to average volume of 756,894 shares.

Click Here to get the full Stock Score Report on Gamida Cell Ltd (GMDA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App